Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
amlodipine (norvasc) (2018)
celecoxib (celebrex) (2018)
amlodipine (norvasc) (2 trials)
celecoxib (celebrex) (2 trials)
cm-24 (1 trial)
nivolumab (opdivo) (1 trial)
paclitaxel (taxol) (1 trial)
Hypertension (Phase 3)
Trials (3 total)
Trial APIs (5 total)